Response to: Correspondence on “Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15” by Ataca Atilla and Atilla 5 de March de 2025 by Tian, G., Courtney, A. N., Heczey, A., Metelitsa, L. S.
Tian, G., Courtney, A. N., Heczey, A., Metelitsa, L. S. 